Surgical treatment of type 2 diabetes mellitus. Analysis of long-term remission

DOI: https://doi.org/10.29296/25877305-2022-12-13
Issue: 
12
Year: 
2022

A. Neimark, Candidate of Medical Sciences; I. Danilov, Candidate of Medical Sciences; A. Shulyakovskaya; S. Lapshina; O. Kornyushin, Candidate of Medical Sciences; M. Salov
Almazov National Medical Research Centre, Saint Petersburg

Type 2 diabetes mellitus (DM2) and obesity are diseases that have a negative impact on public health. They are associated with significant morbidity and mortality, and despite lifestyle changes and the possibility of conservative therapy, it is still difficult to achieve glycemic control. Currently, there are practically no studies in the Russian-language literature on long-term remission after surgical treatment of DM2. This review aimed to identify and summarize evidence of the long-term effect of bariatric surgery on remission of DM2. There is no relationship between the type of bariatric intervention and the fact of remission. Each of the operated patients showed a decrease in overweight and, as a result, an improvement in the course of DM2. Bariatric surgery is now established as an effective and safe therapy for morbid obesity and its associated morbidities. Patients who have not achieved remission, despite this, have an improvement in the quality of life. Bariatric surgery also corrected or alleviated a number of other comorbidities of obesity.
Keywords: 
endocrinology
type 2 diabetes mellitus
obesity
remission
bariatric surgery.

References: 
  1. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. Под ред. И.И. Дедова, М.В. Шестаковой, А.Ю. Майорова. 10-й вып. (дополненный). М., 2021 [Standards of specialized diabetes care. Ed. by Dedov I.I., Shestakova M.V., Mayorov A.Yu. 10th Ed. М., 2021 (in Russ.)]. DOI: 10.14341/DM12802
  2. Adams T., Davidson L., Litwin S. et al. Health benefits of gastric bypass surgery after 6 years. JAMA. 2012; 308 (11): 1122–31. DOI: 10.1001/2012.jama.11164
  3. Affinati A., Esfandiari N., Oral E. et al. Bariatric Surgery in the Treatment of Type 2 Diabetes. Curr Diab Rep. 2019; 19 (12): 156. DOI: 10.1007/s11892-019-1269-4
  4. Arterburn D., Bogart A., Sherwood N. et al. A multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass. Obes Surg. 2013; 23 (1): 93–102. DOI: 10.1007/s11695-012-0802-1
  5. Buchwald H., Estok R., Fahrbach K. et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009; 122 (3): 248–56. DOI: 10.1016/j.amjmed.2008.09.041
  6. Cantay H., Binnetoglu K., Erdogdu U. et al. Comparison of short- and long-term outcomes of bariatric surgery methods: A retrospective study. Medicine (Baltimore). 2022; 101 (38): e30679. DOI: 10.1097/MD.0000000000030679
  7. Chen Y., Corsino L., Shantavasinkul P. et al. Gastric bypass surgery leads to long-term remission or improvement of type 2 diabetes and significant decrease of microvascular and macrovascular complications. Ann Surg. 2016; 263 (6): 1138–42. DOI: 10.1097/SLA.0000000000001509
  8. Chikunguwo S., Wolfe L., Dodson P. et al. Analysis of factors associated with durable remission of diabetes after Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2010; 6 (3): 254–9. DOI: 10.1016/j.soard.2009.11.003
  9. Coleman K., Haneuse S., Johnson E. et al. Long-term microvascular disease outcomes in patients with type 2 diabetes after bariatric surgery: evidence for the legacy effect of surgery. Diabetes Care. 2016; 39 (8): 1400–7. DOI: 10.2337/dc16-0194
  10. Courcoulas A., Gallagher J., Neiberg R. et al. Bariatric Surgery vs Lifestyle Intervention for Diabetes Treatment: 5-Year Outcomes From a Randomized Trial. J Clin Endocrinol Metab. 2020; 105 (3): 866–76. DOI: 10.1210/clinem/dgaa006
  11. DiGiorgi M., Rosen D., Choi J. et al. Re-emergence of diabetes after gastric bypass in patients with mid- to long-term follow-up. Surg Obes Relat Dis. 2010; 6 (3): 249–53. DOI: 10.1016/j.soard.2009.09.019
  12. Guenzi M., Arman G., Rau C. et al. Remission of type 2 diabetes after omega loop gastric bypass for morbid obesity. Surg Endosc. 2015; 29 (9): 2669–74. DOI: 10.1007/s00464-014-3987-7
  13. Gulliford M., Booth H., Reddy M. et al. Effect of contemporary bariatric surgical procedures on type 2 diabetes remission. A population-based matched cohort study. Obes Surg. 2016; 26 (10): 2308–15. DOI: 10.1007/s11695-016-2103-6
  14. Fink J., Seifert G., Blüher M. et al. Obesity Surgery. Dtsch Arztebl Int. 2022; 119 (5): 70–80. DOI: 10.3238/arztebl.m2021.0359
  15. Hsu C., Almulaifi A., Chen J. et al. Effect of bariatric surgery vs medical treatment on type 2 diabetes in patients with body mass index lower than 35: five-year outcomes. JAMA Surg. 2015; 150 (12): 1117–24. DOI: 10.1001/jamasurg.2015.2602
  16. Iaconelli A., Panunzi S., De Gaetano A. et al. Effects of bilio- pancreatic diversion on diabetic complications: a 10-year follow-up. Diabetes Care. 2011; 34 (3): 561–7. DOI: 10.2337/dc10-1761
  17. Kelsey M., Nelson A., Green J. et al. Guidelines for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes: JACC Guideline Comparison. J Am Coll Cardiol. 2022; 79 (18): 1849–57. DOI: 10.1016/j.jacc.2022.02.046
  18. Khorgami Z., Shoar S., Saber A. et al. Outcomes of bariatric surgery versus medical management for type 2 diabetes mellitus: a meta-analysis of randomized controlled trials. Obes Surg. 2019; 29 (3): 964–74. DOI: 10.1007/s11695-018-3552-x
  19. Lee W.-J., Chong K., Lin Y. et al. Laparoscopic sleeve gastrectomy versus single anastomosis (mini-) gastric bypass for the treatment of type 2 diabetes mellitus: 5-year results of a randomized trial and study of incretin effect. Obes Surg. 2014; 24 (9): 1552–62. DOI: 10.1007/s11695-014-1344-5
  20. MacDonald K.G., Long S., Swanson M. et al. The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus. J Gastrointest Surg. 1997; 1 (3): 213–20. DOI: 10.1016/s1091-255x(97)80112-6
  21. Madsen L., Baggesen L., Richelsen B. et al. Effect of Roux-en-Y gastric bypass surgery on diabetes remission and complications in individuals with type 2 diabetes: a Danish population – based matched cohort study. Diabetologia. 2019; 62 (4): 611–20. DOI: 10.1007/s00125-019-4816-2
  22. Mingrone G., Panunzi S., De Gaetano A. et al. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomized controlled trial. Lancet. 2015; 386 (9997): 964–73. DOI: 10.1016/S0140-6736(15)00075-6
  23. Musella M., Apers J., Rheinwalt K. et al. Efficacy of Bariatric Surgery in Type 2 Diabetes Mellitus Remission: the Role of Mini Gastric Bypass/One Anastomosis Gastric Bypass and Sleeve Gastrectomy at 1 Year of Follow-up. A European survey. Obes Surg. 2016; 26 (5): 933–40. DOI: 10.1007/s11695-015-1865-6
  24. Panunzi S., Carlsson L., De Gaetano A. et al. Determinants of diabetes remission and glycemic control after bariatric surgery. Diabetes Care. 2016; 39 (1): 166–74. DOI: 10.2337/dc15-0575
  25. Pories W., Swanson M., MacDonald K.G. et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995; 222 (3): 339–50. DOI: 10.1097/00000658-199509000-00011
  26. Riddle M., Cefalu W., Evans P. et al. Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes. Diabetes Care. 2021; 44 (10): 2438–44. DOI: 10.2337/dci21-0034
  27. Schauer P., Bhatt D., Kirwan J. et al. Bariatric surgery versus intensive medical therapy for diabetes – 5-year outcomes. NEJM. 2017; 376 (7): 641–51. DOI: 10.1056/NEJMoa1600869
  28. Sheng B., Truong K., Spitler H. et al. The Long-Term Effects of Bariatric Surgery on Type 2 Diabetes Remission, Microvascular and Macrovascular Complications, and Mortality: a Systematic Review and Meta-Analysis. Obes Surg. 2017; 27 (10): 2724–32. DOI: 10.1007/s11695-017-2866-4
  29. Sjostrom L., Peltonen M., Jacobson P. et al. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA. 2014; 311 (22): 2297–304. DOI: 10.1001/jama.2014.5988
  30. The American Diabetes Association. Standards of medical care in diabetes – 2013. Diabetes Care. 2013; 36 (Suppl 1): S11–66. DOI: 10.2337/dc13-S011
  31. Yan Y., Sha Y., Yao G. et al. Roux-en-Y Gastric Bypass Versus Medical Treatment for Type 2 Diabetes Mellitus in Obese Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicine (Baltimore). 2016; 95 (17): e3462. DOI: 10.1097/MD.0000000000003462
  32. Zakaria A., Rossetti L., Cristina M. et al. Effects of gastric banding on glucose tolerance, cardiovascular and renal function, and diabetic complications: a 13-year study of the morbidly obese. Surg Obes Relat Dis. 2016; 12 (3): 587–95. DOI: 10.1016/j.soard.2015.10.062